Related Experiment Video
Updated: Oct 10, 2025

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
WNT1-inducible signaling pathway protein 1 regulates kidney inflammation through the NF-κB pathway
Bo Wang1,2, Chenguang Ding1,3, Xiaoming Ding1,3
1Department of Kidney Transplantation, Nephropathy Hospital, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China.
Abstract:
Inflammation is a pathological feature of kidney injury and its progression correlates with the development of kidney fibrosis which can lead to kidney function impairment. This project investigated the regulatory function of WNT1-inducible signaling pathway protein 1 (WISP1) in kidney inflammation. Administration of recombinant WISP1 protein to healthy mice induced kidney inflammation (macrophage accrual and production of tumor necrosis factor α (TNF-α), CCL2 and IL-6), which could be prevented by inhibition of nuclear factor κ-light-chain-enhancer of activated B cells (NF-κB). Furthermore, inhibition of WISP1, by gene knockdown or neutralising antibody, could inhibit cultured macrophages producing inflammatory cytokines following stimulation with lipopolysaccharides (LPSs) and kidney fibroblasts proliferating in response to TNFα, which both involved NF-κB signaling. Kidney expression of WISP1 was found to be increased in mouse models of progressive kidney inflammation-unilateral ureter obstruction (UUO) and streptozotocin (STZ)-induced diabetic nephropathy (DN). Treatment of UUO mice with WISP1 antibody reduced the kidney inflammation in these mice. Therefore, pharmacological blockade of WISP1 exhibits potential as a novel therapy for inhibiting inflammation in kidney disease.
Insights
WNT1-inducible signaling pathway protein 1 (WISP1) drives kidney inflammation by activating nuclear factor κ-light-chain-enhancer of activated B cells (NF-κB). Blocking WISP1 shows potential for treating kidney disease by reducing inflammation.
Area of Science:
- Nephrology
- Immunology
- Molecular Biology
Background:
- Kidney inflammation is a key factor in kidney injury progression and fibrosis.
- The role of WNT1-inducible signaling pathway protein 1 (WISP1) in kidney inflammation requires further investigation.
Purpose of the Study:
- To investigate the regulatory function of WISP1 in kidney inflammation.
- To explore the potential of targeting WISP1 as a therapeutic strategy for kidney disease.
Main Methods:
- Administration of recombinant WISP1 protein and WISP1 inhibition (gene knockdown, neutralizing antibody) in mouse models.
- Assessment of inflammatory markers (macrophage accrual, TNF-α, CCL2, IL-6) and NF-κB signaling.
- Evaluation in unilateral ureter obstruction (UUO) and streptozotocin (STZ)-induced diabetic nephropathy (DN) models.
Main Results:
- Recombinant WISP1 induced kidney inflammation, mediated by NF-κB signaling.
- WISP1 inhibition reduced inflammatory cytokine production in macrophages and fibroblast proliferation.
- WISP1 expression was elevated in UUO and STZ-induced DN mouse models.
- WISP1 antibody treatment decreased kidney inflammation in UUO mice.
Conclusions:
- WISP1 promotes kidney inflammation through NF-κB signaling.
- Pharmacological blockade of WISP1 presents a potential novel therapeutic approach for kidney inflammation in kidney diseases.
More Related Videos
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
TGF - β Signaling Pathway
The JAK-STAT Signaling Pathway
Regulation of the Unfolded Protein Response

